Description
Quick-Reference Overview Matrix
For efficient laboratory evaluation, the matrix below consolidates the core analytical, storage, and cross-reference parameters of Tesamorelin 20mg.
| Core Parameter | Technical Summary & Quick Data | Internal Cross-Reference |
|---|---|---|
| Purity & Grade | ≥ 98% HPLC Certified Sterile filtered, stable lyophilized cake engineered for high-purity assays. | View High-Purity Series → |
| Primary Target Path | GHRH Receptor Agonism: Stimulates endogenous growth hormone secretion; extensively evaluated in lipolysis and metabolic syndrome research. | Metabolic Research Series → |
| Storage Protocol | Lyophilized: -20°C to -80°C (Up to 24 months). Reconstituted: 2°C to 8°C (Must use within 10–14 days). | Buy Reconstitution Diluents → |
| Synergistic Assays | Frequently co-evaluated with other growth hormone secretagogues (GHS) or lipolytic peptides for structural tissue modeling. | Explore Tissue Repair Series → |
What Is Tesamorelin & How Does It Work?
Tesamorelin (also widely documented as a synthetic tesamorelin GHRH analog or tesamorelin growth hormone releasing hormone variant) is a stabilized 44-amino-acid polypeptide. Engineered with a trans-3-hexenoyl group attached to its N-terminal anchor, this specific structural modification enhances its resistance to enzymatic cleavage and extends its biological half-life compared to endogenous GHRH. In modern endocrinology and metabolic research, this tesamorelin research peptide USA standard is heavily utilized to examine growth hormone regulation axes and lipolytic signaling pathways.
Our high-purity tesamorelin 20mg formulation (as well as our standard tesamorelin 10mg peptide option) provides an exceptional baseline for laboratory testing. By stimulating pituitary somatotrophs, it encourages natural pulsatile GH release without disrupting normal negative feedback loops. To review verified batch-specific test results and independent HPLC documentation, visit peptidesk.com.
Tesamorelin 20mg Quick Specifications
| Technical Property | Specification Standard |
|---|---|
| Product Format | 20mg Purified Lyophilized Powder / Vial |
| Sequence | Hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 |
| Molecular Formula | C221H366N72O67S1 |
| Molecular Weight | 5135.9 g/mol |
| Purity Baseline | ≥ 98.0% Certified via HPLC Assays |
| Physical Appearance | Sterile filtered, white lyophilized crystalline cake |
| Core Target Nodes | GHRH Receptor Activation, Visceral Adipose Tissue (VAT) Lipolysis, IGF-1 Generation |
Research Compliance Notice: Products supplied as a tesamorelin research peptide vial standard are provided strictly for laboratory testing, in vitro diagnostics, and scientific profiling. They are strictly not approved for human clinical use, therapy, or personal consumption.
How Does Tesamorelin Work in Laboratory Assays?
Inquiries into how does tesamorelin work at the cellular level reveal a highly selective interaction with GHRH receptors located on pituitary somatotroph cells. Upon binding, the peptide triggers an intracellular cyclic AMP (cAMP) cascade that stimulates the synthesis and secretion of endogenous growth hormone in a natural pulsatile pattern.
Following GH release, the compound activates downstream somatotropic channels:
- The Tesamorelin IGF-1 Pathway: Systemic growth hormone elevation prompts hepatocytes to upregulate Insulin-Like Growth Factor 1 (IGF-1) synthesis, driving tissue repair and cell metabolism.
- Targeted Visceral Lipolysis: Elevated GH and IGF-1 work synergistically to accelerate tesamorelin lipid metabolism, targeting deep visceral adipose tissue (VAT) stores while preserving subcutaneous fat layers.
- Preserved Feedback Loops: Unlike recombinant GH administration, Tesamorelin preserves somatostatin-mediated negative feedback, preventing pituitary suppression in tesamorelin endocrine signaling studies.
Core Pathways & Action Matrix
| Target Pathway | Observed Cellular Action | Primary Research Goal |
|---|---|---|
| GHRH Receptor Agonism | Binds selectively to pituitary receptors to prompt endogenous pulsatile GH release loops. | Quantifying natural somatotroph response rates. |
| Visceral Fat Breakdown | Triggers triglyceride clearance in visceral adipocyte matrices via cAMP-dependent pathways. | Measuring visceral fat volume shrinkage metrics. |
| IGF-1 Hepatic Induction | Stimulates liver cells to increase circulating IGF-1 coenzyme pools natively. | Tracking downstream anabolic signaling kinetics. |
Tesamorelin Applications & Metabolic Body Composition Research
When assessing what is tesamorelin used for in published literature, researchers focus heavily on tesamorelin body composition research and hepatic metabolic assays. Studies demonstrate that selective GHRH agonism reduces visceral adiposity, lowers triglyceride accumulation, and improves liver fat profiles in metabolic disease models.
Primary areas of laboratory evaluation include:
- NASH & Hepatic Steatosis Models: Analyzing reductions in liver fat content and tracking inflammatory gene expression in fatty-liver tissue assays.
- Cognitive Decline & Neuroprotection: Investigating whether GHRH signaling amplification alters somatotropic support paths in age-associated memory models.
- Cardiovascular Lipid Parameters: Monitoring downstream changes in lipid profiles, triglyceride clearance, and metabolic risk markers under controlled conditions.
Research Overview: Benefits vs. Technical Limitations
| Observed Research Benefits | Technical Risks & Limitations |
|---|---|
| • Pulsatile GH Release: Unlike direct exogenous GH introduction, Tesamorelin preserves normal physiologic negative feedback mechanisms, preventing pituitary shutdown. | • Glucose Sensitivity Shifts: Extended exposure in test models can cause minor alterations in baseline glucose levels and insulin sensitivity profiles. |
| • Selective Visceral Lipolysis: Demonstrates high affinity for visceral adipose arrays while leaving secondary subcutaneous tissue layers intact. | • Reconstitution Fragility: Though modified with a hexenoyl anchor, reconstituted liquid solutions remain susceptible to thermal degradation if mismanaged. |
How Does Tesamorelin Compare to Other Research Peptides?
To assist in experimental protocol coordination, the comparison matrix below differentiates Tesamorelin 20mg from alternative growth hormone secretagogues, lipolytic fragments and metabolic regulators in our catalog:
| Research Peptide | Mechanism of Action | Primary Laboratory Focus | Target Nodes | Peptide Structure |
|---|---|---|---|---|
| Tesamorelin 20mg(This Product) | Selective GHRH Agonism | Pulsatile GH release, targeted visceral fat lipolysis, and hepatic IGF-1 induction. | Pituitary GHRH-R | Hexenoyl (44-AA) |
| AOD-9604 5mg | Beta-3 Adrenergic Agonism | Growth-independent fat cell breakdown, triglyceride clearance, and non-glycemic metabolic tracking. | Beta-3 Adrenergic | Truncated (16-AA) |
| GH Stack 10mg Blend | Dual GHRH & GHSR Agonism | Synergistic somatotroph stimulation, pulsatile GH amplification, and recovery profiling. | GHRH-R / GHS-R | Co-Lyophilized Blend |
| Cagrilintide 10mg | Non-Selective AMYR Agonism | Amylin receptor activation, gastric emptying delay, and central satiety signaling models. | AMYR Complex | Acylated Polypeptide |
Storage & Reconstitution Guidelines for Tesamorelin
Because Tesamorelin is a long 44-amino-acid peptide chain, its delicate secondary structure is sensitive to thermal unfolding and mechanical friction. Adhering to strict storage protocols ensures consistent assay baselines over time:
- FREEZER (-20°C)
Unopened Lyophilized Powder: Store dry freeze-dried powder vials in a laboratory freezer at -20°C to -80°C for long-term stability up to 24 months. Protect from light. - TRANSIT RESILIENCE
Unmixed Powder: Highly resilient during transport; can handle ambient shipping temperatures up to 25°C for up to 3 weeks. Refrigerate upon arrival. - REFRIGERATOR (2°C – 8°C)
Reconstituted Liquid Phase: Store mixed liquid solutions under strict refrigeration between 2°C and 8°C. Exhaust active liquid within 10 to 14 days maximum. Do not refreeze liquid solutions.
Step-by-Step Reconstitution Protocol
- Temperature Adaptation: Allow the vial to reach room temperature naturally before opening the cap to prevent condensation moisture from forming inside the glass.
- Septum Sanitization: Wipe the upper rubber entry stopper thoroughly using a fresh, sterile isopropyl alcohol swab.
- Controlled Diluent Addition: Using a sterile syringe, slowly inject 1ml or 2ml of sterile bacteriostatic water down the inside glass wall of the vial rather than spraying directly onto the powder cake.
- Gentle Dissolution: Do not shake or vortex the vial. Mechanical agitation breaks delicate peptide bonds. Gently roll the vial horizontally between your palms until the white cake completely dissolves into a clear liquid.
Tesamorelin Purity, Cost & Buying Online in the USA
When preparing to researching where to buy tesamorelin in the USA, evaluating vendor purity standards and tesamorelin 10mg cost parameters is critical. Low-grade peptides containing truncated sequence errors can compromise receptor binding studies and yield inaccurate laboratory data.
Every lot of our tesamorelin peptide USA inventory undergoes independent High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) testing to guarantee an ultra-high purity baseline (≥98.0% certified). Whether you need to buy tesamorelin 10mg USA stock or source 20mg vials for high-yield testing, place your order directly through peptidesk.com.
Analytical Verification & Lab Reports: Inspect our latest batch-specific HPLC purity charts, mass spectrometry results, and independent COA documents directly on our PeptidesK Third-Party Lab Testing Page.
To browse certified tesamorelin peptide for sale options with fast domestic USA shipping, visit peptidesk.com.
Shop by Goal Categories
Explore our high-purity research compounds and peptides categorized by primary experimental targets and research goals:
| Goal Category | Primary Research Focus |
|---|---|
| Anti-Aging & Longevity Peptides → | Cellular renewal, telomere maintenance, and anti-senescence research models. |
| Fat Loss & Metabolic Peptides → | Incretin mimetics, lipolysis acceleration, and metabolic flexibility profiling. |
| Muscle Growth & Building Peptides → | Anabolic signaling, GH secretagogues, and protein synthesis acceleration. |
| Recovery & Healing Peptides → | Soft tissue repair, tendon-to-bone recovery, and systemic cell migration. |
| Focus & Cognitive Peptides → | Nootropic signaling, neuroprotection, and synaptic plasticity assays. |






There are no reviews yet.